Literature DB >> 15590224

Stress among allogeneic bone marrow transplantation patients.

Heikki Heinonen1, Liisa Volin, Michael A Zevon, Antti Uutela, Chris Barrick, Tapani Ruutu.   

Abstract

BMT (bone marrow transplantation) is acknowledged as one of the most stressful treatments in modern cancer care. When investigating the impact of BMT on patients it is crucial that the analytic method employed captures direct patient perceptions, allowing the patient to define the domains under investigation. In this study, a multivariate analytic method, concept mapping (CM), was used to identify perceived stressors among 109 allogeneic BMT recipients. CM employs multidimensional scaling and hierarchical cluster analyses to empirically identify the structure underlying the investigated conceptual domain. The analyses of the BMT stress data resulted in an eight-cluster solution. The stress clusters, ranked from the most severe to the least severe, were identified as: Change of life and impact of long-lasting treatment; Side-effects; Distress related to treatment outcome and physiological status; Family-related stress; Fear of death and depressive thoughts; Other concerns; Negative social support; and Stress related to lack of information and the medical staff. A number of stressors generated by the patients were quite novel, and identified important information likely to be useful in clinical settings as well as subsequent research with this high-risk population.

Entities:  

Mesh:

Year:  2005        PMID: 15590224     DOI: 10.1016/j.pec.2003.12.007

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  13 in total

1.  Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study.

Authors:  Gerald M Devins; Kenneth Mah; Hans A Messner; Anargyros Xenocostas; Lise Gauvin; Jeffrey H Lipton
Journal:  Support Care Cancer       Date:  2018-02-08       Impact factor: 3.603

2.  Do ongoing lifestyle disruptions differ across cancer types after the conclusion of cancer treatment?

Authors:  Kenneth Mah; Andrea Bezjak; D Andrew Loblaw; Andrew Gotowiec; Gerald M Devins
Journal:  J Cancer Surviv       Date:  2010-12-21       Impact factor: 4.442

3.  Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).

Authors:  S A Mitchell; N Kline Leidy; K H Mooney; W N Dudley; S L Beck; P C LaStayo; E W Cowen; P Palit; L E Comis; M C Krumlauf; D N Avila; N Atlam; D H Fowler; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2009-09-28       Impact factor: 5.483

Review 4.  Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients.

Authors:  C Fiuza-Luces; R J Simpson; M Ramírez; A Lucia; N A Berger
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

Review 5.  Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.

Authors:  Joseph Pidala; Claudio Anasetti; Heather Jim
Journal:  Br J Haematol       Date:  2009-11-16       Impact factor: 6.998

6.  The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).

Authors:  Margaret F Bevans; Sandra A Mitchell; Susan Marden
Journal:  Support Care Cancer       Date:  2008-03-06       Impact factor: 3.603

Review 7.  What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?

Authors:  Steffen T Simon; Anne Pralong; Michael Hallek; Christoph Scheid; Udo Holtick; Marco Herling
Journal:  Ann Hematol       Date:  2021-05-06       Impact factor: 3.673

8.  "Did the trial kill the intervention?" experiences from the development, implementation and evaluation of a complex intervention.

Authors:  Lydia Bird; Antony Arthur; Karen Cox
Journal:  BMC Med Res Methodol       Date:  2011-03-01       Impact factor: 4.615

9.  Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.

Authors:  Margaret F Bevans; Sandra A Mitchell; A John Barrett; Michael Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen
Journal:  Health Qual Life Outcomes       Date:  2011-04-17       Impact factor: 3.186

Review 10.  A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation.

Authors:  K M Phillips; H L McGinty; J Cessna; Y Asvat; B Gonzalez; M G Cases; B J Small; P B Jacobsen; J Pidala; H S L Jim
Journal:  Bone Marrow Transplant       Date:  2013-05-06       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.